BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26345189)

  • 1. Constipation preceding Parkinson's disease: a systematic review and meta-analysis.
    Adams-Carr KL; Bestwick JP; Shribman S; Lees A; Schrag A; Noyce AJ
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):710-6. PubMed ID: 26345189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constipation in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Yao L; Liang W; Chen J; Wang Q; Huang X
    Eur Neurol; 2023; 86(1):34-44. PubMed ID: 36470230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constipation in Parkinson's Disease.
    Quigley EMM
    Semin Neurol; 2023 Aug; 43(4):562-571. PubMed ID: 37579786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
    Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
    J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Parkinson's disease in glaucoma patients: a systematic review and meta-analysis.
    Zhao B; Cheung R; Malvankar-Mehta MS
    Curr Med Res Opin; 2022 Jun; 38(6):955-962. PubMed ID: 35475495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses.
    Bellou V; Belbasis L; Tzoulaki I; Evangelou E; Ioannidis JP
    Parkinsonism Relat Disord; 2016 Feb; 23():1-9. PubMed ID: 26739246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials.
    Kulisevsky J; Pagonabarraga J
    Drug Saf; 2010 Feb; 33(2):147-61. PubMed ID: 20082541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premotor symptoms and the risk of Parkinson's disease: A case-control study in Mexican population.
    Rodríguez-Violante M; de Saráchaga AJ; Cervantes-Arriaga A; Davila-Avila NM; Carreón-Bautista E; Estrada-Bellmann I; Parra-López G; Cruz-Fino D; Pascasio-Astudillo F
    Clin Neurol Neurosurg; 2017 Sep; 160():46-49. PubMed ID: 28644969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.
    Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J
    Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection and risk of Parkinson's disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Chesdachai S; Jaruvongvanich V; Ungprasert P
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):9-13. PubMed ID: 29049127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study.
    Lin CH; Lin JW; Liu YC; Chang CH; Wu RM
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1371-5. PubMed ID: 25293395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraquat exposure and Parkinson's disease: A systematic review and meta-analysis.
    Tangamornsuksan W; Lohitnavy O; Sruamsiri R; Chaiyakunapruk N; Norman Scholfield C; Reisfeld B; Lohitnavy M
    Arch Environ Occup Health; 2019; 74(5):225-238. PubMed ID: 30474499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Association between Statin Use and the Risk of Parkinson's Disease: A Meta-Analysis of Observational Studies.
    Poly TN; Islam MM; Walther BA; Yang HC; Nguyen PA; Huang CW; Shabbir SA; Li YJ
    Neuroepidemiology; 2017; 49(3-4):142-151. PubMed ID: 29145202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: Association of Helicobacter pylori infection with Parkinson's diseases.
    Shen X; Yang H; Wu Y; Zhang D; Jiang H
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28598012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of resistance training on muscle strength and physical function in people with Parkinson's disease: a systematic review and meta-analysis.
    Chung CL; Thilarajah S; Tan D
    Clin Rehabil; 2016 Jan; 30(1):11-23. PubMed ID: 25691582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and Parkinson's disease: a systematic review and meta-analysis.
    Afraie M; Moradi G; Mohammadzedeh P; Azami M; Riyahifar S; Moradi Y
    Acta Neurol Belg; 2023 Aug; 123(4):1209-1223. PubMed ID: 36385247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-motor features of Parkinson's disease in a nested case-control study of US men.
    Hughes KC; Gao X; Baker JM; Stephen C; Kim IY; Valeri L; Schwarzschild MA; Ascherio A
    J Neurol Neurosurg Psychiatry; 2018 Dec; 89(12):1288-1295. PubMed ID: 30076266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease.
    Pagano G; Tan EE; Haider JM; Bautista A; Tagliati M
    Parkinsonism Relat Disord; 2015 Feb; 21(2):120-5. PubMed ID: 25483722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease and cancer: a systematic review and meta-analysis of over 17 million participants.
    Zhang X; Guarin D; Mohammadzadehhonarvar N; Chen X; Gao X
    BMJ Open; 2021 Jul; 11(7):e046329. PubMed ID: 34215604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of faecal incontinence and constipation in adults with central neurological diseases.
    Coggrave M; Norton C
    Cochrane Database Syst Rev; 2013 Dec; (12):CD002115. PubMed ID: 24347087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.